We are live on ! Find out more
SWTX

SpringWorks Therapeutics

Delisted

SWTX was delisted on the 30th of June, 2025.

142 hedge funds and large institutions have $2.86B invested in SpringWorks Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 37 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 11

59% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 37

30% more call options, than puts

Call options by funds: $317K | Put options by funds: $243K

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

6% more funds holding

Funds holding: 134142 (+8)

0.56% more ownership

Funds ownership: 91.19%91.76% (+0.56%)

23% less capital invested

Capital invested by funds: $3.69B → $2.86B (-$830M)

Holders
142
Holders Change
+8
Holders Change %
+5.97%
% of All Funds
2.49%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
21
Increased
59
Reduced
37
Closed
11
Calls
$317K
Puts
$243K
Net Calls
+$74K
Net Calls Change
+$305K
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$19.1M -$1.62M -21,009 -7%
SFM
27
Sphera Funds Management
Israel
$15.7M +$4.07M +52,800 +27%
Bessemer Group
28
Bessemer Group
New Jersey
$15.3M
Goldman Sachs
29
Goldman Sachs
New York
$13.8M +$2.44M +31,610 +17%
CIBC Asset Management
30
CIBC Asset Management
Ontario, Canada
$12.5M +$11.7K +152 +0.1%
Ameriprise
31
Ameriprise
Minnesota
$12.5M +$67.4K +875 +0.4%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$12.4M +$9.27M +120,323 +159%
Charles Schwab
33
Charles Schwab
California
$11.9M -$379K -4,914 -3%
LCM
34
Laurion Capital Management
New York
$11.8M +$45.1K +585 +0.3%
Citadel Advisors
35
Citadel Advisors
Florida
$10.9M -$49.3M -639,889 -79%
SB
36
Samsara BioCapital
California
$10.8M
MWNA
37
Marshall Wace North America
New York
$10.6M +$10.8M +140,114 +518%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
38
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$10.6M +$11.7M +151,500 +1,010%
Two Sigma Investments
39
Two Sigma Investments
New York
$9.28M +$10M +129,757 +788%
CS
40
Candriam SCA
Luxembourg
$8.94M
N
41
Nuveen
North Carolina
$8.9M -$3.36M -43,578 -27%
AAA
42
Affinity Asset Advisors
New York
$7.99M +$7.78M +101,013 +404%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$7.38M +$567K +7,360 +7%
Morgan Stanley
44
Morgan Stanley
New York
$7.18M +$2.47M +32,035 +39%
Deutsche Bank
45
Deutsche Bank
Germany
$7.18M +$537K +6,967 +7%
CCM
46
CAAS Capital Management
New York
$7.15M +$8.68M +112,643 New
Axa
47
Axa
France
$6.84M +$306K +3,972 +4%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$6.45M +$5.88M +76,341 +302%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$6.37M -$1.96M -25,422 -20%
PF
50
Phoenix Financial
Israel
$6.19M +$2.82M +36,615 +60%

SWTX Hedge Fund Activity: Q3 2021 in Review

142 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2021, worth a combined $2.86B — down 23% from $3.69B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SWTX positions and 11 closed out — a net gain of 10 holders — while 59 added to existing stakes and 37 trimmed.

The largest buyer was Bank of America, adding an estimated $28.3M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $77.1M.

  • 142 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2021, up from 134 in Q2 2021.
  • Funds reported $2.86B of SpringWorks Therapeutics stock for Q3 2021, down 23% quarter-over-quarter.
  • 21 funds opened new SpringWorks Therapeutics positions in Q3 2021 and 11 closed out, a net change of +10 holders.
  • The largest SpringWorks Therapeutics buyer in Q3 2021 was Bank of America, an estimated $28.3M added.
  • The largest SpringWorks Therapeutics seller in Q3 2021 was Bain Capital Life Sciences Investors, an estimated $77.1M sold.

Based on aggregated 13F filings for Q3 2021.